Cargando…

Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia

PURPOSE: To report the 9–12-month outcomes of a novel procedure for reduction of low myopia through epithelium-on photorefractive intrastromal cross-linking (PiXL) with customized control of topographic distribution of ultraviolet (UV)-fluence. METHOD: Myopic patients with normal (non-ectatic) corne...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Wee Kiak, Soh, Zhi Da, Choi, Harold Kah Yen, Theng, Julian Thiam Siew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499923/
https://www.ncbi.nlm.nih.gov/pubmed/28721004
http://dx.doi.org/10.2147/OPTH.S137712
_version_ 1783248552284127232
author Lim, Wee Kiak
Soh, Zhi Da
Choi, Harold Kah Yen
Theng, Julian Thiam Siew
author_facet Lim, Wee Kiak
Soh, Zhi Da
Choi, Harold Kah Yen
Theng, Julian Thiam Siew
author_sort Lim, Wee Kiak
collection PubMed
description PURPOSE: To report the 9–12-month outcomes of a novel procedure for reduction of low myopia through epithelium-on photorefractive intrastromal cross-linking (PiXL) with customized control of topographic distribution of ultraviolet (UV)-fluence. METHOD: Myopic patients with normal (non-ectatic) corneas underwent the PiXL procedure for reduction of low myopia. PiXL treatments were delivered through selective application of UVA light based on the refractive error of each patient. Clinical evaluation included safety (corrected distance visual acuity, endothelial cell count, central corneal thickness, anterior ocular health) and efficacy (uncorrected distance visual acuity, manifest refraction, K-mean) examinations. In addition, a patient satisfaction survey was conducted at 9 months post-procedure to evaluate patients’ subjective experience with the procedure. RESULTS: Fourteen myopic eyes (mean manifest refraction spherical equivalent −1.62±0.6D; range −0.75 to −2.65D) of 8 subjects (mean age 30 years old; range 24–51 years old) were enrolled in the study. At 12 months post-procedure, a mean manifest refraction spherical equivalent reduction of 0.72±0.43D (P<0.001) was observed, with a corresponding gain in uncorrected visual acuity of 0.25 logMAR and mean K-mean flattening of 0.47±0.46D. All patients achieved best corrected visual acuity of 20/20 or better from 1 month onward. There were no cases of ocular infection or secondary changes to the crystalline lens and retina due to UV exposure, while transient corneal haze subsided gradually. CONCLUSION: The epithelium-on PiXL procedure was safe and effective in reducing myopic refractive error in this study with up to 12 months follow-up. Early results of this novel application of collagen cross-linking are encouraging but longer-term data in larger studies are required. PRECIS: This paper serves to introduce and report the early clinical results of epithelium-on PiXL, a novel application of cornea cross-linking, in reducing low myopia in Asian eyes, which are under-represented in studies of similar design.
format Online
Article
Text
id pubmed-5499923
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-54999232017-07-18 Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia Lim, Wee Kiak Soh, Zhi Da Choi, Harold Kah Yen Theng, Julian Thiam Siew Clin Ophthalmol Original Research PURPOSE: To report the 9–12-month outcomes of a novel procedure for reduction of low myopia through epithelium-on photorefractive intrastromal cross-linking (PiXL) with customized control of topographic distribution of ultraviolet (UV)-fluence. METHOD: Myopic patients with normal (non-ectatic) corneas underwent the PiXL procedure for reduction of low myopia. PiXL treatments were delivered through selective application of UVA light based on the refractive error of each patient. Clinical evaluation included safety (corrected distance visual acuity, endothelial cell count, central corneal thickness, anterior ocular health) and efficacy (uncorrected distance visual acuity, manifest refraction, K-mean) examinations. In addition, a patient satisfaction survey was conducted at 9 months post-procedure to evaluate patients’ subjective experience with the procedure. RESULTS: Fourteen myopic eyes (mean manifest refraction spherical equivalent −1.62±0.6D; range −0.75 to −2.65D) of 8 subjects (mean age 30 years old; range 24–51 years old) were enrolled in the study. At 12 months post-procedure, a mean manifest refraction spherical equivalent reduction of 0.72±0.43D (P<0.001) was observed, with a corresponding gain in uncorrected visual acuity of 0.25 logMAR and mean K-mean flattening of 0.47±0.46D. All patients achieved best corrected visual acuity of 20/20 or better from 1 month onward. There were no cases of ocular infection or secondary changes to the crystalline lens and retina due to UV exposure, while transient corneal haze subsided gradually. CONCLUSION: The epithelium-on PiXL procedure was safe and effective in reducing myopic refractive error in this study with up to 12 months follow-up. Early results of this novel application of collagen cross-linking are encouraging but longer-term data in larger studies are required. PRECIS: This paper serves to introduce and report the early clinical results of epithelium-on PiXL, a novel application of cornea cross-linking, in reducing low myopia in Asian eyes, which are under-represented in studies of similar design. Dove Medical Press 2017-06-27 /pmc/articles/PMC5499923/ /pubmed/28721004 http://dx.doi.org/10.2147/OPTH.S137712 Text en © 2017 Lim et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Lim, Wee Kiak
Soh, Zhi Da
Choi, Harold Kah Yen
Theng, Julian Thiam Siew
Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia
title Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia
title_full Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia
title_fullStr Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia
title_full_unstemmed Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia
title_short Epithelium-on photorefractive intrastromal cross-linking (PiXL) for reduction of low myopia
title_sort epithelium-on photorefractive intrastromal cross-linking (pixl) for reduction of low myopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499923/
https://www.ncbi.nlm.nih.gov/pubmed/28721004
http://dx.doi.org/10.2147/OPTH.S137712
work_keys_str_mv AT limweekiak epitheliumonphotorefractiveintrastromalcrosslinkingpixlforreductionoflowmyopia
AT sohzhida epitheliumonphotorefractiveintrastromalcrosslinkingpixlforreductionoflowmyopia
AT choiharoldkahyen epitheliumonphotorefractiveintrastromalcrosslinkingpixlforreductionoflowmyopia
AT thengjulianthiamsiew epitheliumonphotorefractiveintrastromalcrosslinkingpixlforreductionoflowmyopia